dition to the standard measurements of pulmonary vascular resistance (PVR), mean pulmonary artery pressure (mPAP) and trans-pulmonary gradient (TPG), pulmonary artery pressure was sampled at 100Hz by a Radi PressureWire. The inflection point of wave reflection was determined as the point of first zero crossing from positive to negative of the fourth derivative of the pressure/time curve. PAI was calculated as the ratio of the difference in pulmonary artery systolic pressure to the pressure at the inflection point of wave reflection over the total pulmonary pulse pressure. Ti was defined as the time between the pulmonary artery diastolic pressure and the inflection point. Results: Mean TPG was 15±10.6mmHg, mean PVR was 2.8±2.3mmHg·min/l and mean mPAP was 29.5±14.4mmHg. There were significant positive correlations between the pulmonary augmentation index and TPG (r=0.61, p<0.005), mPAP (r=0.50, p<0.05) and PVR (r=0.45, p<0.05). There were significant inverse correlations between the time to inflection point and TPG (r=-0.60, p=0.005), PVR (r=-0.57, p<0.05) and with a trend to an inverse correlation with mPAP (r=-0.43, p=0.06).
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Hypertrophy of right ventricular septomarginal trabeculation by cardiac magnetic resonance imaging predicts presence and severity of pulmonary hypertension and outcome Objective: To prospectively evaluate the predictive value of right ventricular (RV) septomarginal trabeculation (SMT) diameter and area by cardiac magnetic resonance (CMR) imaging in patients with the suspicion of pulmonary hypertension (PH). Methods: A total of 99 patients (70.1±7.6 years; 59.6% female) with the suspicion of PH prospectively underwent CMR imaging and right heart catheterization within two weeks. CMR included assessment of cardiac function and dimensions.
SMT maximum diameter and area were also assessed and related to invasive hemodynamics and outcome. Results: By invasive assessment 63 patients suffered from significant PH (mean PA pressure 31.4±11.1 mmHg). SMT diameters and areas ranged from 1.0 to 8.9 mm and from 0.1 to 2.8 cm 2 (mean 3.9±2.1mm, 0.9±0.7cm 2 , respectively). SMT diameter and area were significantly correlated with mean PA pressure (R=0.29, p=0.024 and R=0.34; p=0.007), pulmonary vascular resistance (R=0.28; p=0.033), and serum NT-proBNP (R=0.34, p=0.001 for both). Patients were followed for 353±212 days. By Kaplan Meier analysis, event-free survival was significantly worse in patients with SMT diameter and area above the median of 4.75 mm and 1.0 cm 2 (log rank p=0.014 and 0.002, respectively). Conclusion: Right ventricular SMT diameter and area by CMR are easily measureable, noninvasive indicators for the presence and severity of PH, and are related to outcome. Purpose: Pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH) are rare causes of pulmonary hypertension. They are categorized in Group 1' in Dana Point clinical classification of pulmonary hypertension. Although the diagnosis is based on pathological findings, it is necessary to make an early clinical diagnosis of these diseases because the prognosis is worse than that of other types of pulmonary hypertension. Furthermore, vasodilators sometimes cause fatal pulmonary edema in patients with PVOD/PCH. This study aimed at establishment of a novel clinical prediction rule to diagnose PVOD/PCH and ultimately providing an appropriate therapeutic strategy for these patients. Methods: We have treated 16 patients clinically suspected as PVOD/PCH. In 5 patients, diagnoses were later confirmed by pathological studies. Clinical data obtained at baseline and survival was compared between patients with PVOD/PCH and 122 patients with pulmonary arterial hypertension. Based on the data obtained from these patients, we have developed a scoring system to diagnose PVOD/PCH. Results: The average age of patients with PVOD/PCH was 47.0±4.6 years old and 13 patients (81.3%) were male. Eleven patients had a smoking history. Six minutes walk distance was 226±37 meters and oxygen saturation dropped from 95.8±0.5% to 85.8±1.1% during exercise. DLco was significantly lower than patients with pulmonary arterial hypertension (25.0±2.5 vs. 56.7±2.4%, p<0.05). Chest CT scan shows ground glass opacity in all patients with PVOD/PCH. Lung perfusion scintigraphy showed defect in 9 patients (56.3%). Pulmonary edema occurred in 5 patients (31.3%) after initiation of vasodilation therapy, which is specific for patients with PVOD/PCH. Based on these results, a novel scoring system was designed to clinically diagnose PVOD/PCH. The scoring system is composed of following values: male, smoking history, oxygen desaturation during 6 minutes walk test, DLco, chest CT scan findings, lung perfusion scintigraphy, and pulmonary edema after vasodilation therapy. The sum of the values was calculated and the highest possible score is 10. When the score is over 4, sensitivity is 94% and specificity is 91% for diagnosing PVOD/PCH. Conclusions: Our novel prediction rule for diagnosing PVOD/PCH may offer an early clinical diagnosis of these diseases.
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The impairment of pulmonary function is related to the development of pulmonary hypertension in patients with cystic fibrosis? When evaluated in multivariate analysis, only FEV1 remains significantly associated with PH (p=0.0002; HR 1.1; 1.05, 1.17). Exercise capacity is compromised in patients with PH awaiting lung transplantation and this group has significantly worse results at 6mwt (p=0.01). A lower distance at 6mwt is predictive for a poor prognosis in the studied population even when inserted in multivariate analysis (p=0.007; HR = 0.267; 0.096, 0.747). Conclusion: Pulmonary Hypertension is frequently associated with end-stage CF. A severe decrease of FEV1 is strongly correlated with development of PH. The presence of PH is related to a reduction of the exercise capacity evaluated by 6mwt, which is predictive for adverse outcome in CF patients awaiting lung transplantation. Although our results are still preliminary, this study suggests that pulmonary vasodilators may be used for the treatment of PH in CF patients with advanced lung disease. Background: Pulmonary hypertension (PH) is a severe condition with high morbidity and mortality despite improvement in the therapeutic management. Contemporary prognostic equations derived from large cohorts mainly include invasive measurements. We sought to assess the relationship between echocardiographic characteristics of patients with PH followed up in our center and mortality. 
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